IFG Advisory’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19K | Sell |
158
-24,449
| -99% | -$2.82M | 0.05% | 206 |
|
|
2025
Q4 | $2.59M | Sell |
24,607
-286
| -1% | -$26.8K | 0.11% | 213 |
|
|
2025
Q3 | $2.09M | Sell |
24,893
-48
| -0.2% | -$3.95K | 0.1% | 228 |
|
|
2025
Q2 | $1.97M | Buy |
24,941
+5,137
| +26% | +$408K | 0.1% | 224 |
|
|
2025
Q1 | $1.78M | Buy |
19,804
+422
| +2% | +$39.4K | 0.1% | 229 |
|
|
2024
Q4 | $1.93M | Sell |
19,382
-1,831
| -9% | -$189K | 0.11% | 208 |
|
|
2024
Q3 | $2.41M | Buy |
21,213
+614
| +3% | +$72.9K | 0.15% | 177 |
|
|
2024
Q2 | $2.55M | Sell |
20,599
-60
| -0.3% | -$7.73K | 0.16% | 156 |
|
|
2024
Q1 | $2.73M | Sell |
20,659
-212
| -1% | -$26.1K | 0.2% | 141 |
|
|
2023
Q4 | $2.28M | Sell |
20,871
-2,052
| -9% | -$213K | 0.17% | 159 |
|
|
2023
Q3 | $2.36M | Buy |
22,923
+954
| +4% | +$103K | 0.2% | 135 |
|
|
2023
Q2 | $2.54M | Buy |
21,969
+1,244
| +6% | +$141K | 0.22% | 132 |
|
|
2023
Q1 | $2.2M | Sell |
20,725
-3,796
| -15% | -$410K | 0.21% | 121 |
|
|
2022
Q4 | $2.72M | Sell |
24,521
-11,397
| -32% | -$1.16M | 0.27% | 91 |
|
|
2022
Q3 | $3.09M | Buy |
35,918
+6,690
| +23% | +$597K | 0.28% | 78 |
|
|
2022
Q2 | $2.66M | Sell |
29,228
-1,105
| -4% | -$98K | 0.28% | 80 |
|
|
2022
Q1 | $2.49M | Buy |
30,333
+7,873
| +35% | +$621K | 0.25% | 98 |
|
|
2021
Q4 | $1.72M | Buy |
22,460
+7,955
| +55% | +$634K | 0.17% | 143 |
|
|
2021
Q3 | $1.09M | Buy |
14,505
+1,044
| +8% | +$79.4K | 0.12% | 192 |
|
|
2021
Q2 | $1.05M | Sell |
13,461
-800
| -6% | -$59.5K | 0.12% | 196 |
|
|
2021
Q1 | $1.05M | Buy |
14,261
+1,294
| +10% | +$95.5K | 0.13% | 184 |
|
|
2020
Q4 | $1.01M | Sell |
12,967
-101
| -0.8% | -$7.72K | 0.14% | 167 |
|
|
2020
Q3 | $1.03M | Buy |
13,068
+793
| +6% | +$62.1K | 0.17% | 141 |
|
|
2020
Q2 | $905K | Buy |
12,275
+746
| +6% | +$56.2K | 0.16% | 150 |
|
|
2020
Q1 | $846K | Buy |
11,529
+94
| +0.8% | +$7.39K | 0.19% | 133 |
|
|
2019
Q4 | $992K | Sell |
11,435
-2,185
| -16% | -$179K | 0.18% | 137 |
|
|
2019
Q3 | $1.09M | Sell |
13,620
-4,028
| -23% | -$323K | 0.21% | 119 |
|
|
2019
Q2 | $1.41M | Buy |
17,648
+721
| +4% | +$55.2K | 0.25% | 86 |
|
|
2019
Q1 | $1.34M | Buy |
16,927
+131
| +0.8% | +$9.8K | 0.26% | 87 |
|
|
2018
Q4 | $1.22M | Sell |
16,796
-2,797
| -14% | -$197K | 0.29% | 82 |
|
|
2018
Q3 | $1.33M | Buy |
19,593
+239
| +1% | +$15.2K | 0.25% | 97 |
|
|
2018
Q2 | $1.12M | Sell |
19,354
-1,108
| -5% | -$62.5K | 0.23% | 102 |
|
|
2018
Q1 | $1.06M | Sell |
20,462
-243
| -1% | -$13.1K | 0.24% | 97 |
|
|
2017
Q4 | $1.11M | Buy |
+20,705
| New | +$1.15M | 0.25% | 90 |
|
Other funds holding MRK
VCM
VPM
IFG Advisory's MRK Position: Q1 2026 in Review
IFG Advisory reduced its Merck (MRK) stake by 99% in Q1 2026, selling an estimated $2.82M and leaving 158 shares worth $19K. The position accounts for 0.05% of the portfolio, ranked #206.
IFG Advisory first reported a position in MRK in Q4 2017 and has held it in 34 quarters since. The position peaked at $3.09M in Q3 2022. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- IFG Advisory held 158 shares of Merck worth $19K as of Q1 2026.
- IFG Advisory sold 24,449 Merck shares in Q1 2026, an estimated $2.82M.
- Merck made up 0.05% of IFG Advisory's portfolio in Q1 2026, its #206 holding.
- IFG Advisory first reported a position in Merck in Q4 2017 and has held it in 34 quarters since.
- IFG Advisory's Merck position peaked at $3.09M in Q3 2022.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on IFG Advisory's 13F filing for Q1 2026, filed 12 May 2026.